Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
640K
-
Shares change
-
+612K
-
Total reported value, excl. options
-
$2.08M
-
Value change
-
+$1.98M
-
Number of buys
-
17
-
Number of sells
-
-2
-
Price
-
$3.24
Significant Holders of Dare Bioscience, Inc. - COM NEW (DARE) as of Q3 2024
21 filings reported holding DARE - Dare Bioscience, Inc. - COM NEW as of Q3 2024.
Dare Bioscience, Inc. - COM NEW (DARE) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 640K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (288K shares), AMH Equity Ltd (100K shares), GEODE CAPITAL MANAGEMENT, LLC (89.1K shares), RENAISSANCE TECHNOLOGIES LLC (64.4K shares), STATE STREET CORP (23.5K shares), COMMONWEALTH EQUITY SERVICES, LLC (17.5K shares), BlackRock, Inc. (17K shares), NORTHERN TRUST CORP (15.5K shares), FOUNDERS FINANCIAL SECURITIES LLC (11.6K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (10.5K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.